HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LITS
Lite Strategy, Inc.
There isn't enough reported data to score LITS yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LITS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Unavailable | |
| Strong |
LITS's balance sheet is currently strong, and its profitability is stable, but its revenue is weak. There isn't enough data to rate its cash flow.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LITS PE Valuation
LITS has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LITS Forward outlook
There aren't enough analyst estimates for LITS to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
LITS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.46 | -$0.15 |
| Q2 2026 | -$2.06 | +$0.33 |
| Q1 2026 | -$2.00 | +$2.75 |
| Q4 2025 | -$1.73 | +$4.00 |
| Q3 2025 | -$1.31 | +$5.68 |
| Q2 2025 | -$2.39 | -190% |
| Q1 2025 | -$4.75 | -226% |
| Q4 2024 | -$5.73 | -303% |
LITS is still losing money, but far less than before: $1.46 per share over the past year, against $14.80 at its worst in early 2021.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
LITS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2023 | $65.3M | +648% |
| Q2 2023 | $1.5M | -87% |
| Q1 2023 | $5.9M | -39% |
| Q4 2022 | $32.7M | +177% |
| Q3 2022 | $8.7M | +13% |
| Q2 2022 | $11.4M | -41% |
| Q1 2022 | $9.7M | +301% |
| Q4 2021 | $11.8M | +29% |
LITS's revenue has slid since its 2023 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2023 | 85% | +293 points |
| Q2 2023 | -760% | -619 points |
| Q1 2023 | -278% | -56 points |
| Q4 2022 | 27% | +176 points |
| Q3 2022 | -209% | +51 points |
| Q2 2022 | -142% | -124 points |
| Q1 2022 | -222% | +691 points |
| Q4 2021 | -149% | +61 points |
LITS's operating margin was 85% last quarter, up 293 points from the same quarter a year ago, near the top of its range since 2019.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over LITS on cash generation, producing positive trailing cash flow while its opponent burns cash.
LITS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.2M | +$2.3M |
| Q2 2026 | -$1.2M | +$1.3M |
| Q1 2026 | -$1.5M | +$1.7M |
| Q3 2025 | -$4.5M | +$6.9M |
| Q2 2025 | -$2.5M | +$15.5M |
| Q1 2025 | -$3.3M | -$339K |
| Q3 2024 | -$11.5M | +$7M |
| Q2 2024 | -$18M | -$6.7M |
LITS has burned cash in almost every quarter: −$7M over the past year, against −$22M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over LITS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
LITS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4% | -1.4M shares |
| 1 year | +13% | +3.7M shares |
| 3 years | +398% | +26.5M shares |
| 5 years | +483% | +27.5M shares |
| Available history | +744% | +29.3M shares |
LITS has 33M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4M |
| Q2 2026 | $2.9M |
| Q1 2026 | $1.8M |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
LITS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | -0.1x | Net Cash |
| Q4 2023 | -0.3x | Net Cash |
| Q3 2023 | -0.1x | Net Cash |
LITS has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LITS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 24.0 | Neutral |
LITS's weekly RSI is 40 (neutral) and its Stochastic is 24 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LITS PE vs Healthcare Sector
| Metric | LITS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
LITS has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LITS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 23% below |
| 20 week MA | $1.07 | 15% below |
| 50 week MA | $1.14 | 20% below |
| 100 week MA | $1.98 | 54% below |
| 200 week MA | $3.41 | 73% below |
LITS is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
LITS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.4 | $58.0 | +34% |
| 2021 | $58.0 | $51.4 | -11% |
| 2022 | $51.4 | $5.00 | -90% |
| 2023 | $5.00 | $5.80 | +16% |
| 2024 | $5.80 | $2.44 | -58% |
| 2025 | $2.44 | $1.35 | -45% |
| 2026 YTD | $1.35 | $0.91 | -33% |
LITS has the edge over HIMS on returns for 2026, with the stronger performance.